Howard G. Welgus, Director at Arcutis Biotherapeutics, Inc. (ARQT), sold 10,000 shares at $14.30 ($143K) on 2025-08-01, disclosed to the SEC on 2025-08-05.
Scheduled sale ($143k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.30 | 3,890 | $56K | 38.9% |
| 2 | $14.30 | 6,110 | $87K | 61.1% |
| Total | $14.30 avg | 10,000 | $143K | 100% |
| Filing → |
| ARQT | SELL | 2026-07-17 | $127K | — | Filing → |
| ARQT | SELL | 2026-06-17 | $116K | — | Filing → |
| ARQT | SELL | 2026-05-05 | $164K | — | Filing → |